Choline kinase

From WikiMD's WELLNESSPEDIA

Choline kinase is an enzyme that plays a crucial role in the metabolism of phospholipids, which are essential components of cell membranes. It catalyzes the phosphorylation of choline to form phosphocholine, a key step in the biosynthesis of phosphatidylcholine.

Function[edit]

Choline kinase is involved in the Kennedy pathway, which is the primary route for the synthesis of phosphatidylcholine in eukaryotic cells. This enzyme is responsible for the first step in this pathway, converting choline into phosphocholine using ATP as a phosphate donor. The reaction can be summarized as follows:

Choline + ATP → Phosphocholine + ADP

Isoforms[edit]

There are multiple isoforms of choline kinase, which are encoded by different genes. In humans, the two main isoforms are Choline Kinase Alpha (CHKA) and Choline Kinase Beta (CHKB). These isoforms have distinct tissue distributions and regulatory mechanisms.

Clinical Significance[edit]

Choline kinase has been implicated in various diseases, including cancer. Overexpression of choline kinase, particularly the alpha isoform, has been observed in several types of cancer, such as breast cancer, lung cancer, and prostate cancer. This overexpression is associated with increased levels of phosphocholine, which is thought to contribute to the malignant phenotype by promoting cell proliferation and survival.

Inhibitors[edit]

Due to its role in cancer, choline kinase is considered a potential target for anticancer therapy. Several inhibitors of choline kinase have been developed and are being investigated for their therapeutic potential. These inhibitors aim to reduce the production of phosphocholine and thereby inhibit tumor growth.

Research[edit]

Ongoing research is focused on understanding the regulation of choline kinase activity and its role in cellular metabolism. Studies are also exploring the development of more specific and potent inhibitors that could be used in the treatment of cancer and other diseases associated with dysregulated choline metabolism.

See Also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.